Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trialResearch in context

Summary: Background: In resectable oesophageal squamous cell carcinoma (ESCC), the efficacy of camrelizumab combined with chemotherapy and apatinib followed by minimally invasive oesophagectomy is not clear. We aimed to fill this knowledge gap. Methods: This investigator-initiated, single-arm, pros...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zixiang Wu, Chuanqiang Wu, Jing Zhao, Cong Wu, Haixian Peng, Qi Wang, Rui Bai, Xuefeng Fang, Hong He, Hong Shen, Ming Wu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-05-01
Colecção:	EClinicalMedicine
Assuntos:	Oesophageal squamous cell carcinoma Neoadjuvant therapy Cancer immunotherapy Minimally invasive oesophagectomy
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2589537024001585
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!